Correlation Between Adagene and Oncorus
Can any of the company-specific risk be diversified away by investing in both Adagene and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Oncorus, you can compare the effects of market volatilities on Adagene and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Oncorus.
Diversification Opportunities for Adagene and Oncorus
Very weak diversification
The 3 months correlation between Adagene and Oncorus is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Adagene i.e., Adagene and Oncorus go up and down completely randomly.
Pair Corralation between Adagene and Oncorus
If you would invest 4.35 in Oncorus on September 22, 2024 and sell it today you would earn a total of 0.00 from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Adagene vs. Oncorus
Performance |
Timeline |
Adagene |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adagene and Oncorus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adagene and Oncorus
The main advantage of trading using opposite Adagene and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
CEOs Directory Screen CEOs from public companies around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |